Insight Molecular Diagnostics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell IMDX and other ETFs, options, and stocks.About IMDX
Insight Molecular Diagnostics, Inc. is a molecular diagnostics company, which engages in the development and commercialization of diagnostic tests for the detection of cancer, including molecular diagnostic services to pharmaceutical customers. Its products include DetermaRx and DetermaIO.
CEOJoshua Riggs
CEOJoshua Riggs
Employees49
Employees49
HeadquartersNashville, Tennessee
HeadquartersNashville, Tennessee
Founded2009
Founded2009
Employees49
Employees49
IMDX Key Statistics
Market cap160.81M
Market cap160.81M
Price-Earnings ratio-1.97
Price-Earnings ratio-1.97
Dividend yield—
Dividend yield—
Average volume46.30K
Average volume46.30K
High today$5.69
High today$5.69
Low today$5.27
Low today$5.27
Open price$5.27
Open price$5.27
Volume23.71K
Volume23.71K
52 Week high$8.51
52 Week high$8.51
52 Week low$1.92
52 Week low$1.92
Stock Snapshot
Insight Molecular Diagnostics(IMDX) stock is priced at $5.58, giving the company a market capitalization of 160.81M. It carries a P/E multiple of -1.97.
During the trading session on 2025-12-04, Insight Molecular Diagnostics(IMDX) shares reached a daily high of $5.69 and a low of $5.27. At a current price of $5.58, the stock is +5.9% higher than the low and still -1.9% under the high.
Trading activity shows a volume of 23.71K, compared to an average daily volume of 46.3K.
Over the past 52 weeks, Insight Molecular Diagnostics(IMDX) stock has traded between a high of $8.51 and a low of $1.92.
Over the past 52 weeks, Insight Molecular Diagnostics(IMDX) stock has traded between a high of $8.51 and a low of $1.92.
People also own
Based on the portfolios of people who own IMDX. This list is generated using Robinhood data, and it’s not a recommendation.